Denmark
· Delayed Price · Currency is DKK BioPorto Statistics
Total Valuation
BioPorto has a market cap or net worth of DKK 637.61 million. The enterprise value is 565.89 million.
| Market Cap | 637.61M |
| Enterprise Value | 565.89M |
Important Dates
The next estimated earnings date is Thursday, March 20, 2025.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioPorto has 429.66 million shares outstanding. The number of shares has increased by 13.23% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 429.66M |
| Shares Change (YoY) | +13.23% |
| Shares Change (QoQ) | +8.48% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 4.69% |
| Float | 352.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.72 |
| PB Ratio | 7.37 |
| P/TBV Ratio | 7.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.23 |
| EV / Sales | 16.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.23 |
Financial Position
The company has a current ratio of 5.15, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.15 |
| Quick Ratio | 4.74 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -39.07 |
Financial Efficiency
Return on equity (ROE) is -77.94% and return on invested capital (ROIC) is -45.93%.
| Return on Equity (ROE) | -77.94% |
| Return on Assets (ROA) | -37.81% |
| Return on Capital (ROIC) | -45.93% |
| Revenue Per Employee | 969,611 |
| Profits Per Employee | -1.70M |
| Employee Count | 29 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 3.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.97% in the last 52 weeks. The beta is 1.25, so BioPorto's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -31.97% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 29.85 |
| Average Volume (20 Days) | 422,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioPorto had revenue of DKK 34.91 million and -61.30 million in losses. Loss per share was -0.16.
| Revenue | 34.91M |
| Gross Profit | 24.86M |
| Operating Income | -62.56M |
| Pretax Income | -67.09M |
| Net Income | -61.30M |
| EBITDA | -61.82M |
| EBIT | -62.56M |
| Loss Per Share | -0.16 |
Balance Sheet
The company has 76.34 million in cash and 4.63 million in debt, giving a net cash position of 71.72 million or 0.17 per share.
| Cash & Cash Equivalents | 76.34M |
| Total Debt | 4.63M |
| Net Cash | 71.72M |
| Net Cash Per Share | 0.17 |
| Equity (Book Value) | 86.55M |
| Book Value Per Share | 0.20 |
| Working Capital | 80.61M |
Cash Flow
In the last 12 months, operating cash flow was -68.73 million and capital expenditures -39,000, giving a free cash flow of -68.77 million.
| Operating Cash Flow | -68.73M |
| Capital Expenditures | -39,000 |
| Free Cash Flow | -68.77M |
| FCF Per Share | -0.16 |
Margins
Gross margin is 71.22%, with operating and profit margins of -179.22% and -175.62%.
| Gross Margin | 71.22% |
| Operating Margin | -179.22% |
| Pretax Margin | -192.19% |
| Profit Margin | -175.62% |
| EBITDA Margin | -177.11% |
| EBIT Margin | -179.22% |
| FCF Margin | n/a |
Dividends & Yields
BioPorto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.23% |
| Shareholder Yield | -13.23% |
| Earnings Yield | -10.50% |
| FCF Yield | -10.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioPorto has an Altman Z-Score of 14.96.
| Altman Z-Score | 14.96 |
| Piotroski F-Score | n/a |